logo

Supernus Pharmaceuticals, Inc. (SUPN)



Trade SUPN now with
  Date
  Headline
9/18/2017 4:11:37 PM Supernus Pharmaceuticals, Trading Expected To Resume At 4:30 PM ET
9/18/2017 4:01:31 PM Supernus Pharmaceuticals Trading Halted Pending News
4/3/2017 11:26:00 AM New 52-week Highs On Nasdaq
2/28/2017 8:03:39 PM Supernus Q4 EPS $0.26, 86% Increase Over 2015
2/8/2017 7:08:07 AM Supernus Reports Issuance Of Eighth U.S. Patent Protecting Trokendi XR
10/11/2016 7:50:33 AM Supernus Pharmaceuticals Trading Expected To Resume At 8:15 AM ET
10/11/2016 7:49:52 AM Supernus Announces Positive Results From Phase IIb Clinical Trial For SPN-812 In Children With ADHD